NFRX News Alert Inferx Corporation (NFRX) 0.0013 09/28/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Inferx Corporation (NFRX) 0.0013 $NFRX

InferX Corporation Announces Alliance Agreement with e-Discovery/Technology Firm Crossfield Data Services; Michael Deale Appointed InferX Acting EVP
PR Newswire - Tue Aug 06, 6:00AM CDT
InferX Corporation (OTC/PK: NFRX) finalized a strategic alliance with Crossfield Data Services ("Crossfield" , a leading advanced data analytics and technical support firm offering litigation, compliance, and government investigations support for commercial and government clients. Under terms of the agreement, Crossfield will support InferX's software development program and commercial launch of InferX's analytics products and solutions; provide technical liaison support for InferX's expanding teaming partners; provide communication infrastructure for inferX's upcoming Financial Analytic Management Solutions ("FAMS" cloud-based services; and, assist in developing new analytic solutions to meet emerging client needs. Under terms of the agreement, InferX is also granted first right of refusal for the next twelve (12) months to acquire Crossfield under terms subject to future negotiation.

InferX Corporation Licenses Big Data Predictive Analytics Technology to Funding Profiles; Joint Marketing and Integration Agreement Signed
PR Newswire - Mon Jul 22, 6:00AM CDT
InferX Corporation (OTC/PK: NFRX) and Funding Profiles, Inc. jointly announced a licensing and business development agreement that integrates InferX's proprietary predictive analytic technology and Funding Profiles' upcoming Big Data product. Funding Profiles provides powerful analytic and financial visualization tools, primarily targeting financial planning and analysis staff in Fortune 1000 organizations, enabling companies to assess how well a client's strategic plans relate to the client's revenue segments, global costs, product segmentation, market sectors, target global markets, technology stratification, and other factors.

InferX Corporation Appointed Exclusive Distributor for Ontonix Analytics Technology and Products in North America
PR Newswire - Tue Jul 09, 7:00AM CDT
InferX Corporation (OTC/PK: NFRX) has been appointed exclusive distributor for Ontonix products, including its flagship product, OntoNet(TM), in North America. Ontonix has pioneered the development of innovative Quantitative Complexity Management techniques to support innovative analytics solutions. Ontonix has worked with many leading clients primarily in Italy and Europe, using its family of Quantitative Complexity Management solutions to manage risk and improve performance in the financial, healthcare, and government sectors.

InferX Corporation Expands Management Advisory Board; New Member Appointed
GlobeNewswire - Wed Jun 12, 8:00AM CDT
InferX Corporation (OTCPK:NFRX) is pleased to pleased to announce the appointment of Michael J. Deale as a new member of the InferX Management Advisory Board. Mr. Deale serves as President and CEO of Crossfield Data Services and manages the firm's e-Discovery Data Analytics practice. He has served as principal consultant on a number of e-Discovery projects for complex litigation which typically includes the extraction, review and production and analysis of millions of records from complex enterprise database applications; analysis of software/website/database based intellectual property; analysis of software/website/database in contract disputes; and the retention, reduction, review, processing, and productions of large electronic document collections.

InferX Corporation Expands Management Advisory Board; Two New Members Appointed
GlobeNewswire - Thu Mar 21, 11:44AM CDT
InferX Corporation (OTCPK:NFRX) announced today appointment of two new members to the InferX Management Advisory Board.

A New Audio Interview With Paul B. Silverman, President and CEO of InferX Corporation, is Now at SmallCapVoice.com
GlobeNewswire - Thu Jan 03, 7:00AM CST
SmallCapVoice.com, Inc. announced today that a new audio interview with InferX Corporation (OTCBB:NFRX), a pioneer in advanced predictive analytics solutions in the rapidly growing analytics market addressing health care and other key market sectors, is now available. The interview can be heard at http://smallcapvoice.com/blog/12-31-12-smallc...-corp-nfrx

InferX Corporation Executive Management Team Expanded; Paul B. Silverman Joins as CEO and President; Carl Eckstein Joins Board of Directors
PR Newswire - Thu Dec 27, 3:29PM CST
InferX Corporation (OTC/PK: NFRX) announced today an expanded senior executive management team to support the company's ambitious growth plans developing new advanced predictive analytics solutions in the rapidly growing analytics market addressing health care and other key market sectors.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 378

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 340

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 63

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 247

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 505

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 262

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 425

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 48

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 456

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 468

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading

Top 5 Most Recently Viewed Articles

C3is Inc (CISS) Hits 52-Week Low; Analyzing Market Challenges

Updated Category News Views 210

C3is Inc (CISS) hit a new low recently, dropping to $1.09 a share. This marks a staggering 97.53% decline over the past year, leaving investors scratching their heads about where this company is headed next. C3is Inc: A Company in Crisis As the stock tumbles to its 52-week low, the implications for C3is's market position are glaring. With a market cap of just $6.75...

Continue Reading
Securitas AB Set to Release Q3 2025 Financial Results Soon

Updated Category News Views 308

Securitas AB Announces Release of Q3 2025 Results STOCKHOLM, Oct. 29, 2025 - Securitas AB is gearing up to publish its Interim Report for the period of January to September 2025 on Thursday, November 6, 2025, at 8:00 a.m. CET. This important financial document will provide insights into the company's performance and outlook for the future. Details of the Report Release...

Continue Reading
XRP Whales Drive Demand for ExoraPad's $EXP as Presale Surges

Updated Category News Views 216

XRP Whales Drive Demand for ExoraPad's $EXP as Presale Surges In a remarkable show of confidence, XRP whales are actively positioning themselves to acquire ExoraPad's $EXP tokens, resulting in a presale that has quickly exceeded expectations. This impressive feat has occurred just hours after the presale launch, where over 30% of the softcap has already been raised,...

Continue Reading
Innovative Partnership for Elderly Services and Board Changes

Updated Category News Views 164

Strengthening Services for the Elderly CLIK is thrilled to announce its exciting new partnership with Flash Mutual, a cutting-edge technology firm operating under Tencent's Sustainable Social Value initiatives. This collaboration is designed to deliver round-the-clock instant device services specifically aimed at enhancing the lives of senior citizens. A Focus on...

Continue Reading
Microsoft's Fourth-Quarter Forecast: Anticipating Growth and Innovation

Updated Category News Views 217

Overview of Microsoft's Upcoming Fourth Quarter Earnings Microsoft Corporation (NASDAQ: MSFT) is positioning itself for a robust financial report as it gears up to share its fourth-quarter results. Analysts are excited about the anticipated growth driven by advancements in AI and cloud services, highlighting the company's impressive trajectory in the tech sphere. Earnings...

Continue Reading